Citation Impact
Citing Papers
Sustained hypoxia leads to the emergence of cells with enhanced growth, migratory, and promitogenic potentials within the distal pulmonary artery wall
2009
A Novel Germline Variant in CSF3R Reduces N-Glycosylation and Exerts Potent Oncogenic Effects in Leukemia
2018 StandoutNobel
Decitabine Enhances Lymphocyte Migration and Function and Synergizes with CTLA-4 Blockade in a Murine Ovarian Cancer Model
2015
Arid5a Promotes Immune Evasion by Augmenting Tryptophan Metabolism and Chemokine Expression
2021 StandoutNobel
Chromatin modifiers and the promise of epigenetic therapy in acute leukemia
2014
5-Azacytidine treatment sensitizes tumor cells to T-cell mediated cytotoxicity and modulates NK cells in patients with myeloid malignancies
2014
Targeted glycan degradation potentiates the anticancer immune response in vivo
2020 StandoutNobel
Platelet factor 4–induced T H 1-T reg polarization suppresses antitumor immunity
2024 StandoutScienceNobel
MicroRNA‐142 controls thymocyte proliferation
2017
Messenger RNA-Based Vaccines Against Infectious Diseases
2020 StandoutNobel
Augmenting Antitumor Immune Responses with Epigenetic Modifying Agents
2015
A view on drug resistance in cancer
2019 StandoutNature
Review The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge
2015 Standout
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Cancer nanomedicine: progress, challenges and opportunities
2016 Standout
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
The biology and management of non-small cell lung cancer
2018 StandoutNature
Tumor Suppressor microRNAs Contribute to the Regulation of PD-L1 Expression in Malignant Pleural Mesothelioma
2017
Delivery materials for siRNA therapeutics
2013 Standout
Hypomethylating agents in combination with immune checkpoint inhibitors in acute myeloid leukemia and myelodysplastic syndromes
2018 StandoutNobel
The immune contexture in cancer prognosis and treatment
2017 Standout
Vaccination with Messenger RNA: A Promising Alternative to DNA Vaccination
2020 StandoutNobel
LYTACs that engage the asialoglycoprotein receptor for targeted protein degradation
2021 StandoutNobel
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
2021 StandoutNobel
Metazoan MicroRNAs
2018 Standout
Non-viral vectors for gene-based therapy
2014 Standout
Regulation and Function of the PD-L1 Checkpoint
2018 Standout
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy
2017 Standout
Coinhibitory Receptor Expression and Immune Checkpoint Blockade: Maintaining a Balance in CD8+ T Cell Responses to Chronic Viral Infections and Cancer
2017 StandoutNobel
Clay nanosheets for topical delivery of RNAi for sustained protection against plant viruses
2017 Standout
PGE2-EP2/EP4 signaling elicits immunosuppression by driving the mregDC-Treg axis in inflammatory tumor microenvironment
2022 StandoutNobel
Interferons α and β in cancer: therapeutic opportunities from new insights
2019
Degradation from the outside in: Targeting extracellular and membrane proteins for degradation through the endolysosomal pathway
2021 StandoutNobel
Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
2018 Standout
KATching-Up on Small Molecule Modulators of Lysine Acetyltransferases
2015
Adaptive and Maladaptive Cardiorespiratory Responses to Continuous and Intermittent Hypoxia Mediated by Hypoxia-Inducible Factors 1 and 2
2012 StandoutNobel
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Mutational spectrum of acute myeloid leukemia patients with double CEBPA mutations based on next-generation sequencing and its prognostic significance
2018
The emerging role of immune checkpoint based approaches in AML and MDS
2017 StandoutNobel
Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
2018 StandoutNobel
Induction of cancer testis antigen expression in circulating acute myeloid leukemia blasts following hypomethylating agent monotherapy
2016
PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
2016 Standout
Combination therapy in combating cancer
2017 Standout
Multi-targeted therapy of cancer by niclosamide: A new application for an old drug
2014 Standout
S100A4-induced cell motility and metastasis is restricted by the Wnt/β-catenin pathway inhibitor calcimycin in colon cancer cells
2011
The Essential Medicinal Chemistry of Curcumin
2017 Standout
Cancer immunotherapy using checkpoint blockade
2018 StandoutScience
Works of Xiaoning Gao being referenced
Low Dose Decitabine Treatment Induces CD80 Expression in Cancer Cells and Stimulates Tumor Specific Cytotoxic T Lymphocyte Responses
2013
Silencing of the MYCN gene by siRNA delivered by folate receptor-targeted liposomes in LA-N-5 cells
2010
MicroRNA-142-3p inhibits cell proliferation in human acute lymphoblastic leukemia by targeting the MLL-AF4 oncogene
2013
Demethylating treatment suppresses natural killer cell cytolytic activity
2009
S100A4 antisense oligodeoxynucleotide suppresses invasive potential of neuroblastoma cells
2005
A Histone Acetyltransferase p300 Inhibitor C646 Induces Cell Cycle Arrest and Apoptosis Selectively in AML1-ETO-Positive AML Cells
2013
Mutational spectrum and risk stratification of intermediate-risk acute myeloid leukemia patients based on next-generation sequencing
2016
Epigenetic silencing of microRNA-193a contributes to leukemogenesis in t(8;21) acute myeloid leukemia by activating the PTEN/PI3K signal pathway
2012